0332.KLSE Topvision Eye Specialist Berhad
- Market cap
- MYR 51.1M
- P/E
- 16.5x
- P/B
- 1.15x
- ROE
- 7.5%
- Dividend yield
- 12.12%
- Fundamental score
- 2.5/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 0332.KLSE undervalued?
Graham number0332.KLSE trades 8.2% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Topvision Eye Specialist Berhad fundamental analysis
12 of 22 checks passedROE 0/2
Low return on equity (7.5%), below 10%.
ROA 0/1
Return on assets (4.4%) is below the industry median (5.1%).
Profit Consistency 1/2
Profitable for 4 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (93.2%) is above the industry median (28.6%).
Revenue Growth 1/2
Revenue grew 5.1% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (24.2%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 6.8x against interest expense, well covered.
PE vs Market 0/1
PE (16.5x) is above the market median (11.4x).
PE vs Industry 1/1
PE (16.5x) is below the industry median (22.0x).
PBV 1/1
Price to book (1.1x) is below the industry median (2.9x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 19.0, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 2/2
Dividend yield (12.1%) is in the top 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
Payout ratio is 311.3%, above 90% of earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
About Topvision Eye Specialist Berhad
Topvision Eye Specialist Berhad, together with its subsidiaries, provides ophthalmology healthcare services in Malaysia. The company offers various eye care services for cataract, diabetic retinopathy, retinal detachment, glaucoma, age-related macular degeneration, pterygium, children's eye disorder, and other eye problems, including cornea ulcer, dry eyes, eyelid abscess, foreign body removal, subconjunctival hemorrhage, trauma, and viral conjunctivitis. It also engages in …
Full company profileTopvision Eye Specialist Berhad financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Topvision Eye Specialist Berhad annual financial statements (MYR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 39.5M | 43.0M | 44.2M | 45.8M | 47.7M |
| Gross Profit | 20.1M | 21.2M | 22.6M | 22.9M | 24.7M |
| Operating Income | 9.56M | 8.18M | 4.65M | 4.99M | 7.12M |
| EBITDA | 11.1M | 12.4M | 9.64M | 11.6M | 14.2M |
| Net Income | 6.11M | 4.82M | 1.03M | 1.99M | 3.32M |
| EPS | 0.02 | 0.02 | 0.00 | 0.01 | 0.01 |
| Balance Sheet | |||||
| Total Assets | 47.7M | 50.2M | 78.9M | 75.4M | 76.2M |
| Total Liabilities | 20.7M | 20.2M | 31.1M | 31.6M | 30.5M |
| Shareholders' Equity | 26.7M | 29.4M | 47.0M | 42.8M | 44.5M |
| Cash & Short-term Investments | 6.32M | 6.57M | 10.1M | 10.7M | 9.90M |
| Cash Flow | |||||
| Operating Cash Flow | 10.1M | 8.33M | 8.49M | 7.82M | 8.19M |
| Capital Expenditure | 6.49M | 5.00M | 12.3M | 6.49M | 604K |
| Free Cash Flow | 3.66M | 3.32M | -3.86M | 1.33M | 7.79M |
| Ratios | |||||
| ROE | 22.9% | 16.4% | 2.2% | 4.7% | 7.5% |
| ROA | 12.8% | 9.6% | 1.3% | 2.6% | 4.4% |
| Net Profit Margin | 15.5% | 11.2% | 2.3% | 4.3% | 7.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Topvision Eye Specialist Berhad dividends
- Dividend yield
- 12.12%
- Forward dividend
- 0.02 MYR
- Payout ratio
- 311.3%
- Ex-dividend date
- Sep 14, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | MYR 6.20M | 0.02 | 311.3% |
| 2024 | - | - | - |
| 2023 | MYR 2.04M | 0.01 | 42.4% |
| 2022 | MYR 2.04M | 0.01 | 33.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Topvision Eye Specialist Berhad
- Insiders 87.46%
- Institutions 0.00%
- Public & others 12.55%
- Shares outstanding 310M
- Free float 38.9M
Topvision Eye Specialist Berhad company profile
- Company name
- Topvision Eye Specialist Berhad
- Ticker
- 0332.KLSE
- Exchange
- Kuala Lumpur Exchange
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Fiscal year end
- December
- Address
- No. 2, Block 2, Jalan Setia Prima (S) U13/S, Shah Alam, Malaysia, 40170
- Phone
- 60 3 5037 1675
- Website
- tvesc.com
About Topvision Eye Specialist Berhad
Topvision Eye Specialist Berhad, together with its subsidiaries, provides ophthalmology healthcare services in Malaysia. The company offers various eye care services for cataract, diabetic retinopathy, retinal detachment, glaucoma, age-related macular degeneration, pterygium, children's eye disorder, and other eye problems, including cornea ulcer, dry eyes, eyelid abscess, foreign body removal, subconjunctival hemorrhage, trauma, and viral conjunctivitis. It also engages in the provision of related medical consultancy services; marketing of eye supplements and health food products; retail sale of food and beverage; and import, export, and distribution of pharmaceuticals, medical devices and goods, cosmetics, and health supplements. The company was founded in 2010 and is headquartered in Shah Alam, Malaysia.
Topvision Eye Specialist Berhad management
4- Dr. Kuok Siong ChongCEO & Executive Director · born 1977
- Mr. Hock Nean Liew B.Sc., M.B.A., M.Sc.Founder & Executive Vice Chairman · born 1956
- Ms. Mei Hui TanChief Financial Officer · born 1984
- Ms. Yoke Voon SoongChief Operating Officer · born 1980